Education
About Us
Working with TipRanks
Follow Us
Sanara MedTech (SMTI)
:SMTI
Total Valuation
Sanara MedTech has a market cap or net worth of $188.27M. The enterprise value is $306.80M.
Market Cap$188.27M
Enterprise Value$306.80M
Share Statistics
Sanara MedTech has 8,935,657 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,935,657
Owned by Insiders41.76%
Owned by Institutions1.53%
Financial Efficiency
Sanara MedTech’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is -9.18%.
Return on Equity (ROE)-0.25
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-9.18%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee614.70K
Profits Per Employee-70.30K
Employee Count141
Asset Turnover0.98
Inventory Turnover2.96
Valuation Ratios
The current PE Ratio of Sanara MedTech is ―. Sanara MedTech’s PEG ratio is -0.24.
PE Ratio―
PS Ratio3.25
PB Ratio7.15
Price to Fair Value7.15
Price to FCF-1.23K
Price to Operating Cash Flow48.28
PEG Ratio-0.24
Income Statement
In the last 12 months, Sanara MedTech had revenue of 86.67M and earned -9.66M in profits. Earnings per share was -1.14.
Revenue86.67M
Gross Profit78.53M
Operating Income-6.72M
Pretax Income-9.91M
Net Income-9.66M
EBITDA-1.86M
Earnings Per Share (EPS)-1.14
Cash Flow
In the last 12 months, operating cash flow was 3.77M and capital expenditures -4.64M, giving a free cash flow of -865.50K billion.
Operating Cash Flow3.77M
Free Cash Flow-865.50K
Free Cash Flow per Share-0.10
Dividends & Yields
Sanara MedTech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.17
52-Week Price Change-48.93%
50-Day Moving Average29.64
200-Day Moving Average30.40
Relative Strength Index (RSI)24.51
Average Volume (3m)46.61K
Important Dates
Sanara MedTech upcoming earnings date is Apr 1, 2026, Before Open (Confirmed).
Last Earnings DateNov 12, 2025
Next Earnings DateApr 1, 2026
Ex-Dividend Date―
Financial Position
Sanara MedTech as a current ratio of 2.18, with Debt / Equity ratio of 770.74%
Current Ratio2.18
Quick Ratio2.00
Debt to Market Cap0.11
Net Debt to EBITDA-8.82
Interest Coverage Ratio-2.15
Taxes
In the past 12 months, Sanara MedTech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Sanara MedTech EV to EBITDA ratio is -160.24, with an EV/FCF ratio of -1.30K.
EV to Sales3.44
EV to EBITDA-160.24
EV to Free Cash Flow-1.30K
EV to Operating Cash Flow-12.53K
Balance Sheet
Sanara MedTech has $14.94M in cash and marketable securities with $47.39M in debt, giving a net cash position of -$32.45M billion.
Cash & Marketable Securities$14.94M
Total Debt$47.39M
Net Cash-$32.45M
Net Cash Per Share-$3.63
Tangible Book Value Per Share-$0.67
Margins
Gross margin is 92.25%, with operating margin of -7.75%, and net profit margin of -11.15%.
Gross Margin92.25%
Operating Margin-7.75%
Pretax Margin-11.44%
Net Profit Margin-11.15%
EBITDA Margin-2.15%
EBIT Margin-7.83%
Analyst Forecast
The average price target for Sanara MedTech is $41.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$41.00
Price Target Upside38.89% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast30.55%
EPS Growth Forecast-340.19%